L49.2
Exfoliation due to erythematous condition involving 20-29 percent of body surface
Clinical Classification Guidelines
Medical Intelligence & Overview
Exfoliation due to erythematous condition, classified under ICD-10 code L49.2, refers to skin peeling or shedding resulting from an inflammatory redness of the skin covering a significant portion of the body. This condition encompasses scenarios where 20-29% of the body's surface area is affected, leading to widespread skin concerns that can impact daily activities and comfort. Recognizing the underlying factors, symptoms, and available management strategies is essential for understanding this skin condition.
Causes & Symptoms
Clinical Causes: Severe reactions to medications or drugs, such as antibiotics or anticonvulsants Infections caused by bacteria, viruses, or fungi leading to skin inflammation Autoimmune skin disorders, including psoriasis or lupus erythematosus Dermatologic conditions like erythema multiforme or Stevens-Johnson syndrome Environmental factors, such as exposure to harsh chemicals or extreme weather conditions Underlying systemic diseases that provoke skin inflammation
Key Symptoms: Extensive redness or erythema covering 20-29% of the body surface Peeling or shedding of skin in large sheets or flakes Swelling and tenderness in the affected areas Itching or burning sensation in the inflamed skin Presence of blistering or raw skin in severe cases Fever or malaise if associated with underlying infections or systemic reactions
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a detailed clinical examination by a healthcare provider, focusing on the extent and appearance of skin redness and peeling. Medical history questions may target recent medication use, infections, or other systemic symptoms. Sometimes, skin biopsies, blood tests, or cultures are performed to identify underlying causes or rule out other skin conditions. The key criterion is involvement of 20-29% of the body surface area with erythematous, peeling skin.
Treatment Protocols: Discontinuing or replacing triggering medications if identified Using topical corticosteroids or anti-inflammatory agents to reduce skin inflammation Applying moisturizers and emollients to maintain skin hydration Administering systemic medications, such as corticosteroids or immunosuppressants, in severe cases Treating any associated infections with appropriate antibiotics, antivirals, or antifungals Implementing supportive care measures, including hydration, pain management, and infection prevention Monitoring for complications like secondary infections or dehydration
Clinical Advice & FAQs
Billing Guidance
Is L49.2 a billable ICD-10 code?
Yes, L49.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L49.2?
Clinical documentation must specify the nature of Exfoliation due to erythematous condition involving 20-29 percent of body surface and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
